Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cochlear.
RELATED STOCKHEAD STORIES
Health & Biotech
Scott Power: ASX health stocks feel force of market volatility
Health & Biotech
Health Check: More healthcare ‘reverse ferrets’ from Trump’s razor gang
Health & Biotech
Health Check: Half-price sale as brokers ring the bell on Neuren shares
Experts
Criterion: Rollercoaster price movements are now part of the profit-reporting landscape
Health & Biotech
Scott Power: ASX healthcare stocks fall in ‘worst reporting season for a long time’
Health & Biotech
Dr Boreham’s Crucible: This hearing-aid stock is well tuned in to an evolving, competitive field
Health & Biotech
Health Check: Brokers slash Cochlear valuations as customers hold tight on product upgrades
News
Closing Bell: ASX ends week in decent nick; Trump-Putin talks lift spirits
Health & Biotech
Scott Power: Chemist Warehouse and Sigma officially say ‘I do’ as CSL & Cochlear feels heartache
News
Lunch Wrap: ASX feeling Valentine’s Day love but Cochlear, AMP get the cold shoulder
Health & Biotech
Scott Power: ASX health stocks drop as Trump’s proposed tariffs rattle global markets
Health & Biotech
Health Check: Good golly Miss Molly! Emyria says Ecstasy works for PTSD, months after treatment
Health & Biotech
Health Check: Did the earth move for you? The world shifts on its axis as it enters the Trump era mark two
Health & Biotech
Biocurious: With its pre-budget ‘wish list’, Ausbiotech prepares to bat for the sector in Canberra
Health & Biotech
Health Check: Local biotech starred in 2024, but the rising tide did not lift all boats
Health & Biotech
Biocurious: Painchek’s aged care and infant market expansion plans could be much-needed salve
Health & Biotech
